Literature DB >> 16002671

IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.

Nuno L Alves1, Fernando A Arosa, René A W van Lier.   

Abstract

Human naive CD8+ T cells are able to respond in an Ag-independent manner to IL-7 and IL-15. Whereas IL-7 largely maintains CD8+ T cells in a naive phenotype, IL-15 drives these cells to an effector phenotype characterized, among other features, by down-regulation of the costimulatory molecule CD28. We evaluated the influence of the CD4+ Th cell-derived common gamma-chain cytokine IL-21 on cytokine-induced naive CD8+ T cell activation. Stimulation with IL-21 did not induce division and only slightly increased IL-15-induced proliferation of naive CD8+ T cells. Strikingly, however, IL-15-induced down-modulation of CD28 was completely prevented by IL-21 at the protein and transcriptional level. Subsequent stimulation via combined TCR/CD3 and CD28 triggering led to a markedly higher production of IL-2 and IFN-gamma in IL-15/IL-21-stimulated cells compared with IL-15-stimulated T cells. Our data show that IL-21 modulates the phenotype of naive CD8+ T cells that have undergone IL-15 induced homeostatic proliferation and preserves their responsiveness to CD28 ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002671     DOI: 10.4049/jimmunol.175.2.755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Telomerase induction in T cells: a cure for aging and disease?

Authors:  Rita B Effros
Journal:  Exp Gerontol       Date:  2006-12-19       Impact factor: 4.032

2.  Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy.

Authors:  Matthias Wölfl; Katharina Merker; Henner Morbach; Stefaan W Van Gool; Matthias Eyrich; Philip D Greenberg; Paul G Schlegel
Journal:  Cancer Immunol Immunother       Date:  2010-10-24       Impact factor: 6.968

3.  IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span.

Authors:  Huy Nguyen; Nan-ping Weng
Journal:  J Leukoc Biol       Date:  2009-10-01       Impact factor: 4.962

4.  IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Authors:  Ho Ngai; Gengwen Tian; Amy N Courtney; Soodeh B Ravari; Linjie Guo; Bin Liu; Jingling Jin; Elise T Shen; Erica J Di Pierro; Leonid S Metelitsa
Journal:  J Immunol       Date:  2018-08-15       Impact factor: 5.422

5.  Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis.

Authors:  Bon-A Cho; Ji Hyun Sim; Ji Ah Park; Hye Won Kim; Wan-Hee Yoo; Seung-Hyun Lee; Dong-Sup Lee; Jae Seung Kang; Young-Il Hwang; Wang Jae Lee; Insoo Kang; Eun Bong Lee; Hang-Rae Kim
Journal:  J Clin Immunol       Date:  2012-02-25       Impact factor: 8.317

Review 6.  Interleukin-21: a multifunctional regulator of immunity to infections.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

Review 7.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.

Authors:  Aude G Chapuis; Gunnar B Ragnarsson; Hieu N Nguyen; Colette N Chaney; Jeffrey S Pufnock; Thomas M Schmitt; Natalie Duerkopp; Ilana M Roberts; Galina L Pogosov; William Y Ho; Sebastian Ochsenreither; Matthias Wölfl; Merav Bar; Jerald P Radich; Cassian Yee; Philip D Greenberg
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

9.  IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.

Authors:  Christian S Hinrichs; Rosanne Spolski; Chrystal M Paulos; Luca Gattinoni; Keith W Kerstann; Douglas C Palmer; Christopher A Klebanoff; Steven A Rosenberg; Warren J Leonard; Nicholas P Restifo
Journal:  Blood       Date:  2008-02-14       Impact factor: 22.113

10.  Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

Authors:  Shicheng Yang; Yun Ji; Luca Gattinoni; Ling Zhang; Zhiya Yu; Nicholas P Restifo; Steven A Rosenberg; Richard A Morgan
Journal:  Cancer Immunol Immunother       Date:  2012-12-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.